Red Nucleus boosts its service offering by adding a leading provider of medical affairs and commercialization services
Red Nucleus, a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired PPM Advisory Group and OrtleyBio, a leading provider of scientific operations and communications services to biopharmaceutical companies and brands, with its primary focus in oncology and hematology therapeutic areas.
PPM offers commercial, medical affairs, and MSL content development; planning and training support, advisory boards, competitive landscape analysis, sales representative training support, and conferences/congress coverage. PPM also brings new client relationships and touch points for the combined business. PPM’s solutions align closely with RN’s existing Commercial and Medical Communications (INVIVO) businesses.
“We are excited to join the Red Nucleus family as we’ll be able to provide expanded services to our current clients while helping them develop and commercialize treatments for patients. Red Nucleus is known to deliver best-in-class services and has an employee and client-service focused culture, which melds well with the PPM culture,” says PPM Founder Rino Mariconda.
“We are thrilled for Rino and the PPM team to join the Red Nucleus family. The combination of PPM and RN will collectively help us expand both within current therapeutic areas and services, as well as grow into new areas and offerings. PPM has a deep bench of advanced-degreed and seasoned medical writers and staff (13 PhDs) who produce high-quality content. Together, we now have more talented team members to build upon the strong historical reputation of both RN and PPM, while delivering leading science-first services that our clients expect and deserve,” adds Red Nucleus CEO Ian Kelly.
Fairmount Partners represented PPM in the sale.
The transaction closed in April 2021.
About Red Nucleus
Red Nucleus is the premier provider of strategic learning, performance, and process solutions exclusively for the life sciences industry. Our global solutions engage and inspire teams across the commercial, medical, and R&D spaces and are designed to boost understanding, efficacy, and compliance.
Squarely focused on the life sciences industry for close to 30 years, Red Nucleus takes pride in our long-term relationships with industry leaders, as well as our strategic partnerships with innovative startups. Red Nucleus is headquartered in Yardley, PA. The company also has offices in Malvern, PA; Boston, MA; Toronto, Canada; London, UK; Stockholm, Sweden; Pune, India; and Tokyo, Japan.
Visit www.rednucleus.com to learn more.
About Fairmount Partners
Fairmount Partners (www.fairmountpartners.com) is an independent merger and acquisition advisory firm focused on emerging growth and middle-market companies. Fairmount helps its clients complete mergers and acquisitions; raise funds for growth, acquisitions and liquidity; and design and improve their corporate development strategies. Fairmount’s clients include successful entrepreneurs, private equity-sponsored enterprises, and global public companies. Since 2003, Fairmount has completed more than 240 transactions, representing over $12 billion in aggregate value, in 20 countries throughout North and South America, Europe, Asia and Australia. For further information, please contact Neal McCarthy at neal.mccarthy@fairmountpartners.com.
